Bone Biologics Corp Cash Flow Quality Index

Latest as of December 2022: -2.18x

Bone Biologics Corp cash flow quality index. Bone Biologics Corp (BBLG) has a Cash Flow Quality Index of -2.18x as of December 2022. Operating cash flow of $-1.95 Million is below net income of $893.46K, suggesting accrual-heavy earnings not yet converted to cash. See BBLG FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.

Cash Flow Quality Index

-2.18x
Operating CF / Net Income

Operating Cash Flow

$-1.95 Million
USD

Net Income

$893.46K
USD

Data as of

Dec 2022
Most recent filing

Bone Biologics Corp Cash Flow Quality Index by Year (None–None)

Bone Biologics Corp cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Bone Biologics Corp. For the full cash flow conversion analysis, see cash flow conversion of Bone Biologics Corp.

Year Quality Index Operating CF (USD) Net Income YoY Change
Cash Flow Quality Index = Operating Cash Flow / Net Income. Ratios above 1.0x indicate cash-backed earnings.